KR20050074428A - 미코플라스마 갈리셉티쿰 포뮬레이션 - Google Patents

미코플라스마 갈리셉티쿰 포뮬레이션 Download PDF

Info

Publication number
KR20050074428A
KR20050074428A KR1020057000554A KR20057000554A KR20050074428A KR 20050074428 A KR20050074428 A KR 20050074428A KR 1020057000554 A KR1020057000554 A KR 1020057000554A KR 20057000554 A KR20057000554 A KR 20057000554A KR 20050074428 A KR20050074428 A KR 20050074428A
Authority
KR
South Korea
Prior art keywords
strain
algae
prophylactic amount
vaccine
mycoplasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020057000554A
Other languages
English (en)
Korean (ko)
Inventor
클레븐스탠리에이치.
페르구손나올라
Original Assignee
더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 filed Critical 더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드
Publication of KR20050074428A publication Critical patent/KR20050074428A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020057000554A 2002-07-13 2003-07-10 미코플라스마 갈리셉티쿰 포뮬레이션 Withdrawn KR20050074428A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/194,180 US7217420B2 (en) 2002-07-13 2002-07-13 Mycoplasma gallisepticum formulation
US10/194,180 2002-07-13

Publications (1)

Publication Number Publication Date
KR20050074428A true KR20050074428A (ko) 2005-07-18

Family

ID=30114683

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057000554A Withdrawn KR20050074428A (ko) 2002-07-13 2003-07-10 미코플라스마 갈리셉티쿰 포뮬레이션

Country Status (11)

Country Link
US (2) US7217420B2 (https=)
EP (1) EP1531861A4 (https=)
JP (1) JP2005533116A (https=)
KR (1) KR20050074428A (https=)
CN (1) CN1688336A (https=)
AU (1) AU2003267992A1 (https=)
BR (1) BR0312640A (https=)
MX (1) MXPA05000467A (https=)
RU (1) RU2005104100A (https=)
WO (1) WO2004006851A2 (https=)
ZA (1) ZA200500169B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110123748A (ko) * 2009-01-22 2011-11-15 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 미코플라스마 갈리셉티쿰 제형

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080026386A1 (en) * 2006-03-31 2008-01-31 Behrens Timothy W Irf-5 haplotypes in systemic lupus erythematosus
TWI422594B (zh) * 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
TW200918666A (en) * 2007-09-11 2009-05-01 Wyeth Corp Attenuated mycoplasma gallisepticum strains
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
AU2014234452B2 (en) * 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
CN119816588A (zh) * 2022-04-06 2025-04-11 乔治亚大学研究基金公司 鸡毒支原体活疫苗

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1137306A (en) 1966-07-11 1968-12-18 Research Corp Inoculum for poultry
JPS52134019A (en) 1976-04-28 1977-11-09 Biseibutsu Kagaku Kenkiyuushiy Micoplasma galicepticum infection vaccine
US5004607A (en) 1987-08-25 1991-04-02 University Of Georgia Research Foundation, Inc. Method of immunizing poultry
ES2058237T3 (es) 1987-09-18 1994-11-01 Akzo Nv Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
CA1339260C (en) 1988-06-02 1997-08-12 Kazumi Kodama Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
WO1993024646A1 (fr) 1992-05-29 1993-12-09 Nippon Zeon Co., Ltd. Antigene de mycoplasme aviaire, son gene, vecteur recombine contenant ledit gene, et vaccin prepare a l'aide de celui-ci
AU691175B2 (en) 1993-03-31 1998-05-14 Nippon Zeon Co., Ltd. Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof
ATE196773T1 (de) 1993-07-30 2000-10-15 Akzo Nobel Nv Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
JPH07133295A (ja) 1993-08-27 1995-05-23 Nippon Zeon Co Ltd 新規な抗原タンパク質、その遺伝子、及び組み換えバキュロウイルスとその利用
JPH07228542A (ja) 1994-02-18 1995-08-29 Nippon Seibutsu Kagaku Kenkyusho 不活化病原体の鶏用気管内投与ワクチン
EP0802796B1 (en) 1995-01-06 2001-10-04 Akzo Nobel N.V. Chicken anaemia agent broiler vaccine
ZA978434B (en) 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110123748A (ko) * 2009-01-22 2011-11-15 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 미코플라스마 갈리셉티쿰 제형

Also Published As

Publication number Publication date
ZA200500169B (en) 2006-06-28
BR0312640A (pt) 2005-06-28
EP1531861A4 (en) 2006-10-11
WO2004006851A2 (en) 2004-01-22
AU2003267992A1 (en) 2004-02-02
EP1531861A2 (en) 2005-05-25
US7217420B2 (en) 2007-05-15
US20040009179A1 (en) 2004-01-15
JP2005533116A (ja) 2005-11-04
AU2003267992A8 (en) 2004-02-02
WO2004006851A3 (en) 2004-03-18
US20060257414A1 (en) 2006-11-16
CN1688336A (zh) 2005-10-26
MXPA05000467A (es) 2005-09-30
RU2005104100A (ru) 2005-08-27

Similar Documents

Publication Publication Date Title
DE69937571T2 (de) Mutiertes cholera holotoxin als hilfsmittel
JP5789897B2 (ja) マイコプラズマ・ボビス ワクチン
KR20140108603A (ko) 약독화된 소 바이러스성 설사 바이러스를 포함하는 복합 백신
Boulianne et al. Pasteurellosis and other respiratory bacterial infections
JP2004536106A (ja) マイコプラズマ・ボビスワクチンおよび動物の肺炎を減少させる方法
CN102851257A (zh) 一种鸡传染性支气管炎病毒减毒疫苗株及其应用
US6585981B1 (en) Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
JP2013223511A6 (ja) マイコプラズマ・ボビス ワクチン
JP2011500093A6 (ja) マイコプラズマ・ボビス ワクチン
KR101654023B1 (ko) 돼지유행성설사병바이러스 약독화주 및 불활화백신 조성물과 이를 이용한 경구 투여용 백신 조성물
CN119816588A (zh) 鸡毒支原体活疫苗
KR20050074428A (ko) 미코플라스마 갈리셉티쿰 포뮬레이션
EP2389433B1 (en) Mycoplasma gallisepticum formulation
EP2912198B1 (en) Immunogenic composition against aeromonas hydrophila
KR0127116B1 (ko) 전염성 점액낭 질병의 예방을 위한 왁찐
EP0802796B1 (en) Chicken anaemia agent broiler vaccine
WO2008074783A1 (en) Immune stimulant against fish pathogenic bacteria
Limsatanun Development of inactivated mycoplasma gallisepticum vaccine in chickens
WO1994005783A1 (en) Novel haemophilus organism and vaccines containing the same
HK1161289B (en) Mycoplasma gallisepticum formulation
AU2001277207A2 (en) Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
KR20060105763A (ko) 에리시펠로트릭스루시오페이취에(Ｅｒｙｓｉｐｅｌｏｔｈｒｉｘｒｈｕｓｉｏｐａｔｈｉａｅ)-헤모필루스파라수이스(Ｈａｅｍｏｐｈｉｌｕｓ Ｐａｒａｓｕｉｓ)백신 및 이들을 이용하는 방법

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20050111

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid